Regeneron Pharma (REGN) PT Raised to $540 at Argus
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $833.56 +0.61%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
Argus analyst Jasper Hellweg raised the price target on Regeneron Pharma (NASDAQ: REGN) to $540.00 (from $430.00) while maintaining a Buy rating.
You May Also Be Interested In
- Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
- Global-E Online Ltd (GLBE) PT Raised to $47 at Truist Securities
- Rush Enterprises Inc. (RUSHA) PT Raised to $85 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
